Human Embryonic Stem Cell Differentiation
In the Foo lab, we are continuously generating hES-derived cardiomyocytes as an in-vitro model of human heart development and disease.
The protocol in our Lab is optimised and modified from the published protocol by Lian et al (Lian et al. 2012). With 80-95% differentiation efficiency, our differentiated cardiomyocytes start to beat from day 14.